Similar articles

• Stem cell proliferation inhibitors.

  Wright EG, Pragnell IB. Wright EG, et al. Baillieres Clin Haematol. 1992 Jul;5(3):723-39. doi: 10.1016/s0950-3536(11)80014-4. Baillieres Clin Haematol. 1992. PMID: 1457966 Review. No abstract available.
• The stem cell compartment: assays and negative regulators.

  Wright EG, Pragnell IB. Wright EG, et al. Curr Top Microbiol Immunol. 1992;177:137-49. doi: 10.1007/978-3-642-76912-2_11. Curr Top Microbiol Immunol. 1992. PMID: 1638868 Review. No abstract available.
• Macrophage inflammatory protein-1 alpha mediated growth inhibition in a haemopoietic stem cell line is associated with inositol 1,4,5 triphosphate generation.

  Heyworth CM, Pearson MA, Dexter TM, Wark G, Owen-Lynch PJ, Whetton AD. Heyworth CM, et al. Growth Factors. 1995;12(3):165-72. doi: 10.3109/08977199509036876. Growth Factors. 1995. PMID: 8619922
• Treating cancer: the potential role of stem cell inhibitors.

  Graham GJ, Pragnell IB. Graham GJ, et al. Eur J Cancer. 1991;27(8):952-3. doi: 10.1016/0277-5379(91)90256-d. Eur J Cancer. 1991. PMID: 1832902 No abstract available.
• Negative regulators of haemopoiesis--current advances.

  Graham GJ, Pragnell IB. Graham GJ, et al. Prog Growth Factor Res. 1990;2(3):181-92. doi: 10.1016/0955-2235(90)90004-4. Prog Growth Factor Res. 1990. PMID: 2132955 Review.